Human Th17 cells in patients with cancer Friends or foe?

被引：18

作者：

Greten, Tim F. ^{[1
]}

Zhao, Fei ^{[1
]}

Gamrekelashvili, Jaba ^{[1
]}

Korangy, Firouzeh ^{[1
]}

机构：

[1] NCI, Gastrointestinal Malignancy Sect, Med Oncol Branch, Bethesda, MD 20892 USA

来源：

ONCOIMMUNOLOGY | 2012年 / 1卷 / 08期

关键词：

IL-17; CCR4; CCR6; liver; cancer; HEPATOCELLULAR-CARCINOMA;

D O I：

10.4161/onci.21245

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

The role of interleukin-17 (IL-17)-secreting CD4(+) T (Th17) cells in cancer is under intense investigation. We have demonstrated that CCR4(+) CCR6(+) Th17 cells not only are increased in the peripheral blood of patients affected by hepatocellular carcinoma, but also suppress CD8(+) T-cell functions in vitro. These results suggest that Th17 cells may exert immunosuppressive functions in hepatocellular carcinoma.

引用

页码：1438 / 1439

页数：2

共 9 条

[1]

Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells [J].

Acosta-Rodriguez, Eva V. ;

Rivino, Laura ;

Geginat, Jens ;

Jarrossay, David ;

Gattorno, Marco ;

Lanzavecchia, Antonio ;

Sallusto, Federica ;

Napolitani, Giorgio .

NATURE IMMUNOLOGY, 2007, 8 (06) :639-646

[2]

Chalmin F, 2012, IMMUNITY

[3]

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells [J].

Hoechst, Bastian ;

Ormandy, Lars A. ;

Ballmaier, Matthias ;

Lehner, Frank ;

Krueger, Christine ;

Manns, Michael P. ;

Greten, Tim F. ;

Korangy, Firouzeh .

GASTROENTEROLOGY, 2008, 135 (01) :234-243

[4]

Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells [J].

Hoechst, Bastian ;

Gamrekelashvili, Jaba ;

Manns, Michael P. ;

Greten, Tim F. ;

Korangy, Firouzeh .

BLOOD, 2011, 117 (24) :6532-6541

[5]

Th17 cells: positive or negative role in tumor? [J].

Ji, Yuqiang ;

Zhang, Wanggang .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (07) :979-987

[6]

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma [J].

Korangy, F ;

Ormandy, LA ;

Bleck, JS ;

Klempnauer, A ;

Wilkens, L ;

Manns, MP ;

Greten, TF .

CLINICAL CANCER RESEARCH, 2004, 10 (13) :4332-4341

[7]

IL-17 and Th17 Cells [J].

Korn, Thomas ;

Bettelli, Estelle ;

Oukka, Mohamed ;

Kuchroo, Vijay K. .

ANNUAL REVIEW OF IMMUNOLOGY, 2009, 27 :485-517

[8]

Are we ready to start studies of Th17 cell manipulation as a therapy for cancer? [J].

Middleton, Gary W. ;

Annels, Nicola E. ;

Pandha, Hardev S. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (01) :1-7

[9]

Increased intratumoral IL-17-producing cells survival in hepatocellular carcinoma correlate with poor patients [J].

Zhang, Jing-Ping ;

Yan, Jing ;

Xu, Jing ;

Pang, Xiong-Hao ;

Chen, Min-Shan ;

Li, Li ;

Wu, Changyou ;

Li, Sheng-Ping ;

Zheng, Limin .

JOURNAL OF HEPATOLOGY, 2009, 50 (05) :980-989

← 1 →